FI
ABEO icon

Fosun International’s Abeona Therapeutics ABEO Stock Holding History

Fosun International’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,956
Closed -$471K – 229
2019
Q2 		$471K Hold
3,956
– – 0.03% 222
2019
Q1 		$719K Buy
3,956
+1,080
+38% +$193K 0.05% 191
2018
Q4 		$477K Buy
+2,876
New +$627K 0.03% 227

Other funds holding ABEO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International's ABEO Position: Q3 2019 in Review

Fosun International sold out of Abeona Therapeutics (ABEO) in Q3 2019, closing a stake of 3,956 shares — an estimated $471K sold.

Fosun International first reported a position in ABEO in Q4 2018 and held it in 3 quarters. The position peaked at $719K in Q1 2019. 79 funds tracked by Wall St. Rank hold ABEO as of Q3 2019.

  • Fosun International reported no remaining Abeona Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 3,956 Abeona Therapeutics shares in Q3 2019, an estimated $471K.
  • Fosun International first reported a position in Abeona Therapeutics in Q4 2018 and held it in 3 quarters.
  • Fosun International's Abeona Therapeutics position peaked at $719K in Q1 2019.
  • 79 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.